<--- Back to Details
First PageDocument Content
Clinical research / Pharmacy / Japan External Trade Organization / Pharmaceutical industry / European Federation of Pharmaceutical Industries and Associations / Shire plc / Biopharmaceutical / Orphan drug / Pharmaceutical sciences / Pharmacology / Pharmaceuticals policy
Date: 2014-08-06 04:26:46
Clinical research
Pharmacy
Japan External Trade Organization
Pharmaceutical industry
European Federation of Pharmaceutical Industries and Associations
Shire plc
Biopharmaceutical
Orphan drug
Pharmaceutical sciences
Pharmacology
Pharmaceuticals policy

JAPAN EXTERNAL TRADE ORGANIZATION Past JETRO Client Shire Poised to Capture Opportunities in the Japanese Pharmaceutical Market Shire’s Japan office playing a key role in taking advantage of regulatory changes and the

Add to Reading List

Source URL: www.jetro.go.jp

Download Document from Source Website

File Size: 1,76 MB

Share Document on Facebook

Similar Documents

The EVMS Autism Spectrum Disorder Program was started by Maria Urbano, M.D., and Kathrin Hartmann, Ph.D., in 2010 to provide clinical services, research, and community outreach to individuals and their families for Autis

The EVMS Autism Spectrum Disorder Program was started by Maria Urbano, M.D., and Kathrin Hartmann, Ph.D., in 2010 to provide clinical services, research, and community outreach to individuals and their families for Autis

DocID: 1vrwY - View Document

Towards a Composite Clinical Endpoint: Identifying a Core Set of Patient and Caregiver Relevant Outcome Measures Through Qualitative Research on the Global Impact of Dravet Syndrome Rima Nabbout1, Stephane Auvin2, Cather

Towards a Composite Clinical Endpoint: Identifying a Core Set of Patient and Caregiver Relevant Outcome Measures Through Qualitative Research on the Global Impact of Dravet Syndrome Rima Nabbout1, Stephane Auvin2, Cather

DocID: 1vpIt - View Document

Clinical Research Registration at Public Registry

Clinical Research Registration at Public Registry

DocID: 1vnxr - View Document

Grattoni Alessandro, Ph.D. Chairman, The Department of Nanomedicine, The Houston Methodist Research Institute, Houston, Texas (USA) Dr. Grattoni’s research is dedicated to the development and clinical translation of im

Grattoni Alessandro, Ph.D. Chairman, The Department of Nanomedicine, The Houston Methodist Research Institute, Houston, Texas (USA) Dr. Grattoni’s research is dedicated to the development and clinical translation of im

DocID: 1vi9N - View Document

Clinical & Translational Research 101 Thursday, August 10, 2017 Time Location

Clinical & Translational Research 101 Thursday, August 10, 2017 Time Location

DocID: 1vglz - View Document